OncoGenex Pharmaceuticals Inc. (ACHV) Shares Up 19.1%
OncoGenex Pharmaceuticals Inc. (NASDAQ:ACHV) shot up 19.1% on Wednesday . The stock traded as high as $2.15 and last traded at $1.68. 5,155,600 shares were traded during trading, an increase of 6,117% from the average session volume of 82,931 shares. The stock had previously closed at $1.41.
Separately, ValuEngine downgraded shares of OncoGenex Pharmaceuticals from a “hold” rating to a “sell” rating in a research report on Friday, September 1st.
OncoGenex Pharmaceuticals (NASDAQ:ACHV) last released its earnings results on Thursday, November 9th. The biopharmaceutical company reported ($0.90) EPS for the quarter.
ILLEGAL ACTIVITY WARNING: This story was first reported by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of United States & international trademark & copyright laws. The original version of this story can be accessed at https://www.watchlistnews.com/oncogenex-pharmaceuticals-inc-achv-shares-up-19-1/1722968.html.
OncoGenex Pharmaceuticals Company Profile
Achieve Life Sciences, Inc, formerly OncoGenex Pharmaceuticals, Inc, is a clinical-stage biopharmaceutical company engaged in the development and commercialization of therapies that address treatment resistance in cancer patients. The Company’s segment is dedicated to the development and commercialization of cancer therapies, with operations located in Canada and the United States.
Receive News & Ratings for OncoGenex Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OncoGenex Pharmaceuticals Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.